Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,184,869 papers from all fields of science
Search
Sign In
Create Free Account
CDK9 protein, human
Known as:
CDK-9 protein, human
, Tat-Associated Kinase Complex Catalytic Subunit
, C-2K
Expand
Cyclin-dependent kinase 9 (372 aa, ~43 kDa) is encoded by the human CDK9 gene. This protein plays a role in the positive regulation of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
23 relations
CDK12 protein, human
CDK2 protein, human
CDK3 protein, human
CDK4 protein, human
Expand
Broader (1)
Cyclin-Dependent Kinase 9
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Transient induction of Cdk9 in the early stage of differentiation is critical for myogenesis
Vahideh Tarhriz
,
S. Eyvazi
,
+4 authors
M. Hejazi
Journal of Cellular Biochemistry
2019
Corpus ID: 195757369
Cdk9 is a serine‐threonine protein kinase that has been recognized as a regulator of cardiac differentiation. Recently, we have…
Expand
2017
2017
miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
Chi Pang
,
Gang Huang
,
+5 authors
W. Cai
Cancer Medicine
2017
Corpus ID: 40727339
miR‐206 plays an important role in regulating the growth of multiple cancer cells. Cyclin‐dependent kinase 9 (CDK9) stimulates…
Expand
2016
2016
Molecular principle of the cyclin-dependent kinase selectivity of 4-(thiazol-5-yl)-2-(phenylamino) pyrimidine-5-carbonitrile derivatives revealed by molecular modeling studies.
Xiaotian Kong
,
Huiyong Sun
,
+4 authors
Tingjun Hou
Physical Chemistry, Chemical Physics - PCCP
2016
Corpus ID: 205955613
Due to the high sequence identity of the binding pockets of cyclin-dependent kinases (CDKs), designing highly selective…
Expand
2014
2014
Genetic Analysis of the Structure and Function of 7SK Small Nuclear Ribonucleoprotein (snRNP) in Cells*
K. Fujinaga
,
Zeping Luo
,
B. Peterlin
Journal of Biological Chemistry
2014
Corpus ID: 24932506
Background: HEXIM1 and LaRP7 bind to 7SK snRNA. Results: HEXIM1 and LaRP7 activation domain chimeras activated plasmid targets…
Expand
Review
2011
Review
2011
Novel, selective CDK9 inhibitors for the treatment of HIV infection.
G. Németh
,
Z. Varga
,
+10 authors
L. Őrfi
Current Medicinal Chemistry
2011
Corpus ID: 39046441
Cyclin Dependent Kinases (CDKs) are important regulators of cell cycle and gene expression. Since an up-to-date review about the…
Expand
Review
2008
Review
2008
RNA‐driven cyclin‐dependent kinase regulation: When CDK9/cyclin T subunits of P‐TEFb meet their ribonucleoprotein partners
A. Michels
,
O. Bensaude
Biotechnology Journal
2008
Corpus ID: 7042117
The positive transcription elongation factor (P‐TEFb) consists of CDK9, a cyclin‐dependent kinase and its cyclin T partner. It is…
Expand
2006
2006
HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription.
Robert L. Caldwell
,
K. Lane
,
V. Shepherd
Archives of Biochemistry and Biophysics
2006
Corpus ID: 25852049
Review
2004
Review
2004
HIV-1 infection and regulation of Tat function in macrophages.
Li‐Ying Liou
,
C. Herrmann
,
A. P. Rice
International Journal of Biochemistry and Cell…
2004
Corpus ID: 33070848
Highly Cited
2002
Highly Cited
2002
Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol.
W. F. de Azevedo
,
F. Canduri
,
N. J. F. da Silveira
Biochemical and Biophysical Research…
2002
Corpus ID: 8363753
Highly Cited
2001
Highly Cited
2001
The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9.
S. Lavoie
,
A. Albert
,
H. Handa
,
M. Vincent
,
O. Bensaude
Journal of Molecular Biology
2001
Corpus ID: 31278040
We identify and characterize several phosphorylated forms of the hSpt5 subunit of the DRB sensitivity-inducing factor (DSIF). A…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE